1-8 of 8
Carlos Gomez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Azacitidine and Venetoclax in High-Risk Myelodysplastic Syndrome: A Real-World Perspective from the Glam Registry with Long-Term Follow-up

Elia Ixel Apodaca Chavez, Renee Crisp, Ana Laura Varela Constantino, Alicia I Enrico, Andres Gomez-De Leon, Roberto Ovilla-Martínez, Sr., Priscilla Wernicke, Carlos Camargo Molano, Matilde Boada, Elvira D. R. P. Velloso, Sergio Schusterschitz, Laura Kornblihtt, Adriana Karola Puente, Breno Gusmao, Sofia Grille, Fernando Barroso, Carlos Gomez, Martha Alvarado Ibarra, Gabriela Rangel, Marcelo Iastrebner
Journal: Blood
Blood (2024) 144 (Supplement 1): 6718.
https://doi.org/10.1182/blood-2024-209513
Published: 2024
Journal Articles

Prior Immune Effector Cell Therapy, Is Not Associated with an Increased Infectious Risk of Subsequent Bispecific Antibody Therapy for Multiple Myeloma

Lawrence Liu, Scott R. Goldsmith, Sheryl Leahey, Carlos Gomez Luna, Shawn Streeter, Adam Braun, Nitya Nathwani, Michael Rosenzweig, Firoozeh Sahebi, Azra Borogovac, Jonathan Keats, Myo Htut, Arnab Chowdhury, Sanjeet Singh Dadwal, Amrita Krishnan, Murali Janakiram
Journal: Blood
Blood (2023) 142 (Supplement 1): 1987.
https://doi.org/10.1182/blood-2023-188077
Published: 2023
Journal Articles

Improving Patient Selection for Phase I Trials in Hematology: An External Validation of the Gustave Roussy Scoring System at Toulouse University Cancer Institute, Oncopole (IUCT-O)

Noemie Gadaud, Carlos Gomez Roca, Loic Ysebaert, Aurore Perrot, Myriam Estrabaut, Muriel Poublanc, Iphigenie Korakis, Christian Recher, Jean Pierre Delord, Thomas Filleron, Pierre Bories
Journal: Blood
Blood (2022) 140 (Supplement 1): 5045–5046.
https://doi.org/10.1182/blood-2022-167063
Published: 2022
Journal Articles

Analysis of Clinical Characteristics and Survival of Multiple Myeloma Patients with Fractures

Luis Carlos Gómez Mier, MD, Vanessa Salinas Alvarez, Alejandro Ras El Abiad, Camilo Soto Montoya, Humberto Martínez Cordero, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17.
https://doi.org/10.1182/blood-2020-138570
Published: 2020
Journal Articles

New Genomic Model Integrating Clinical Factors and Gene Mutations to Predict Overall Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Joo Y. Song, MD, Anamarija M. Perry, MD, Alex F. Herrera, MD, Lu Chen, PhD, Pam Skrabek, MD, Michel Nasr, MD, Rebecca Ottesen, Janet Nikowitz, Victoria Bedell, Joyce Murata-Collins, PhD, Yuan Yuan Chen, Yuping Li, PhD, Carlos Gomez Luna, Christine McCarthy, Raju Pillai, MD, Jinhui Wang, Xiwei Wu, Jasmine Zain, MD, Auayporn P. Nademanee, MDBS, Joyce Niland, PhD, Qiang Gong, Wing C Chan, MD, Dennis D. Weisenburger, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 346.
https://doi.org/10.1182/blood-2018-99-117636
Published: 2018
Journal Articles

Mutations in the Phosphoinositide 3-Kinase Pathway (PI3K) Are Associated with Poor Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Joo Y. Song, MD, Anamarija M. Perry, MD, Alex F. Herrera, MD, Pam Skrabek, MD, Michel Nasr, MD, Rebecca Ottesen, Janet Nikowitz, Victoria Bedell, Joyce Murata-Collins, PhD, Yuan Yuan Chen, Yuping Li, PhD, Carlos Gomez Luna, Christine McCarthy, Raju Pillai, MD, Jinhui Wang, Xiwei Wu, PhD, Jasmine M. Zain, MD, Auayporn P. Nademanee, MDBS, Joyce Niland, PhD, Qiang Gong, PhD, Wing C Chan, MD, Dennis D. Weisenburger, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2740.
https://doi.org/10.1182/blood.V130.Suppl_1.2740.2740
Published: 2017
Journal Articles

A Phase 1 Study of the BET-Bromodomain Inhibitor OTX015 in Patients with Advanced Acute Leukemia

Hervé Dombret, MD PhD, Claude Preudhomme, MD PhD, Céline Berthon, MD, Emmanuel Raffoux, MD, Xavier Thomas, MD PhD, Norbert Vey, MDPhD, Carlos Gomez-Roca, MD, Mark Ethell, MD, Karen Yee, MD, Fabrice Bourdel, MSc, Patrice Herait, MD PhD, Mauricette Michallet, MD PhD, Christian Recher, MDPhD, Christophe Roumier, Bruno Quesnel, MD
Journal: Blood
Blood (2014) 124 (21): 117.
https://doi.org/10.1182/blood.V124.21.117.117
Published: 2014
Journal Articles

A Multicenter, Phase IV Observational Study Of Ofatumumab In Chronic Lymphocytic Leukemia (CLL): A European Research Initiative On CLL (ERIC) Study

Carol Moreno, MD, Marco Montillo, MD, Panayiotidis Panayiotis, MD, Adrian Bloor, PhD, FRCP, FRCPath, Jehan Dupuis, MD, Anna Schuh, MD, PhD, Stefan Norin, MD, Christian H Geisler, Peter Hillmen, MB ChB, PhD, Michael Doubek, Prof., Petra Obrtlikova, MD, Luca Laurenti, MD, Stephan Stilgenbauer, MD, Lukas Smolej, MD, PhD, Paolo Ghia, MD, PhD, Florence Cymbalista, MD, PhD, Ulrich Jaeger, Niki Stavroyianni, Patrick Carrington, MD, Hamadi Zouabi, MD, Veronique Leblond, MD, Juan Carlos Gomez, MD, Roberto Marasca, MD, Gerardo Musuraca, MD, PHD, Luigi Rigacci, MD, Lucia Farina, Rossella Paolini, Sarka Pospisilova, Prof., Eva Kimby, MD, Colm Bradley, Emili Montserrat, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1645.
https://doi.org/10.1182/blood.V122.21.1645.1645
Published: 2013